Abbott Laboratories Reports Strong Q2 Earnings and Raises Full-Year Outlook
Abbott Laboratories (ABT) reported second-quarter earnings that exceeded expectations, with adjusted diluted EPS of $1.31 against a forecast of $1.28. The company also raised its full-year guidance for both sales growth and adjusted diluted EPS.
Tickers: $ABT
Topics: diagnostics earnings healthcare medical_devices